[1] |
Rombach SM, Hollak CE, Linthorst GE, et al. Cost-effectiveness of enzyme replacement therapy for Fabry disease[J]. Orphanet J Rare Dis, 2013, 8:29.
doi: 10.1186/1750-1172-8-29
pmid: 23421808
|
[2] |
中国法布里病专家协作组. 中国法布里病(Fabry病)诊治专家共识[J]. 中华医学杂志, 2013, 93(4):243-247.
|
|
Chinese expert collaboration group on Fabry disease. Expert consensus on diagnosis and treatment of Fabry disease in China[J]. Natl Med J China, 2013, 93(4):243-247.
|
[3] |
潘晓霞, 欧阳彦, 王朝晖, 等. 法布里病83例临床病理特点分析[J]. 中国实用内科杂志, 2014, 34(3):262-266.
|
|
Pan XX, Ouyang Y, Wang CH, et al. Clinical and pathological characteristics of 83 cases of Fabry disease[J]. Chin J Pract Int Med, 2014, 34(3):262-266.
|
[4] |
MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males[J]. J Med Genet, 2001, 38(11):750-760.
pmid: 11694547
|
[5] |
Tanaka M, Ohashi T, Kobayashi M, et al. Identification of Fabry′s disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients[J]. Clin Nephrol, 2005, 64(4):281-287.
pmid: 16240899
|
[6] |
Bekri S, Enica A, Ghafari T, et al. Fabry disease in patients with end-stage renal failure: the potential benefits of screening[J]. Nephron Clin Pract, 2005, 101(1):c33-c38.
doi: 10.1159/000085709
pmid: 15886492
|
[7] |
Gal A, Hughes DA, Winchester B. Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group[J]. J Inherit Metab Dis, 2011, 34(2):509-514.
doi: 10.1007/s10545-010-9261-9
pmid: 21229318
|
[8] |
Patel V, O'Mahony C, Hughes D, et al. Clinical and genetic predictors of major mardiac events in patients with Anderson-Fabry disease[J]. Heart, 2015, 101(12):961-966.
doi: 10.1136/heartjnl-2014-306782
URL
|
[9] |
Hagège A, Réant P, Habib G, et al. Fabry disease in cardiology practice: Literature review and expert point of view[J]. Arch Cardiovasc Dis, 2019, 112(4):278-287.
doi: S1875-2136(19)30039-7
pmid: 30826269
|
[10] |
Yogasundaram H, Kim D, Oudit O, et al. Clinical features, diagnosis, and management of patients with anderson-Fabry cardiomyopathy[J]. Can J Cardiol, 2017, 33(7):883-897.
doi: S0828-282X(17)30207-6
pmid: 28668140
|
[11] |
Schiffmann R, Swift C, McNeill N, et al. Low frequency of Fabry disease in patients with common heart disease[J]. Genet Med, 2018 Jul, 20(7):754-759.
doi: 10.1038/gim.2017.175
pmid: 29227985
|
[12] |
Capelli I, Aiello V, Gasperoni L, et al. Kidney transplant in Fabry disease: a revision of the literature[J]. Medicina (Kaunas), 2020, 56(6):284.
|